Biotech

All Articles

ArsenalBio raises $325M, turns away from former lead possession

.Collection Biosciences is carrying on up. The tissue therapy company has actually added on $325 mil...

Lilly- backed weight reduction biotech data IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has submitted t...

Aelis' cannabis make use of medicine fails phase 2b, steering Indivior to review $100M possibility

.Aelis Farma's hopes of getting an easy, favorable choice on a $one hundred million choice payment h...

ProKidney halts stage 3 test certainly not needed to have for tissue treatment authorization

.ProKidney has stopped one of a set of phase 3 trials for its own tissue treatment for kidney ailmen...

Vaxcyte surges on 'remarkable' 31-valent PCV win versus Pfizer

.Vaxcyte introduced what professionals called "sensational" stage 1/2 data for its own 31-valent pne...

Recursion's brain ailment trial shows little evidence of effectiveness

.Recursion has stumbled with an early exam of its own tech-enabled method to drug discovery, stating...

Acepodia, Pfizer click on all together for chemistry-based tissue treatment

.Call it an instance of really good chemical make up: Acepodia, a biotech based on Nobel Prize-winni...

Praxis epilepsy medication decreases seizures in period 2 hearing

.Practice Preciseness Medicines has scored yet another midphase win in epilepsy this year, along wit...

Three officers surrender as Dyne messages mixed information for DMD applicant

.After running away a medical grip several years back, Dyne Therapy has shown brand-new period 1/2 r...

Arrowhead fires off phase 3 data in uncommon metabolic illness in front of market clash with Ionis

.Arrowhead Pharmaceuticals has actually shown its own hand before a possible showdown along with Ion...